Literature DB >> 17504210

Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain.

Ryszard Pluta1.   

Abstract

This review demonstrated that ischemic brain injury induces chronic changes in blood-brain barrier in the gray and white matter. This insufficiency of blood-brain barrier may allow entry of uncellular blood components such as different fragments of amyloid precursor protein and cellular blood components like leukocytes and platelets into the brain parenchyma. These blood components may have chronic harmful effects on the ischemic neuronal cells, axons and myelin and can intensify and finish the neuropathology in ischemic brain parenchyma. Pathological accumulation of different toxic fragments of amyloid precursor protein in extracellular space and myelinated axons appears after ischemic blood-brain barrier injury and seem to be concomitant with, but independent of neuronal ischemic cytoplasmic injury. It seems that ischemic blood-brain barrier disturbances may play an important, both direct and indirect role in the pathogenesis of extra- and intracellular space in gray and white matter lesions following ischemic episode. This neuropathology appears to have similar character and distribution as in sporadic Alzheimer's disease. This review presented chronic micro-blood-brain barrier openings in ischemic gray and white matter lesions that probably would act as seeds of future Alzheimer's amyloid plaques.

Entities:  

Mesh:

Year:  2007        PMID: 17504210     DOI: 10.2174/156720207780637207

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  19 in total

Review 1.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

2.  Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia.

Authors:  M A Koike; F G Garcia; M Kitazawa; K N Green; F M Laferla
Journal:  Neurosci Lett       Date:  2011-03-23       Impact factor: 3.046

Review 3.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 4.  Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta.

Authors:  Xiang Li; Yifei Ma; Xu Wei; Yanpeng Li; Huijuan Wu; Jianhua Zhuang; Zhongxin Zhao
Journal:  Neurosci Bull       Date:  2013-12-19       Impact factor: 5.203

5.  Still debating a cause and diagnostic criteria for Alzheimer's disease.

Authors:  Bogdan O Popescu
Journal:  J Cell Mol Med       Date:  2007-11-20       Impact factor: 5.310

6.  Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Marzena U Amek
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

Review 7.  Protein Aggregation in the Pathogenesis of Ischemic Stroke.

Authors:  Shusheng Wu; Longfei Du
Journal:  Cell Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.046

Review 8.  Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Wanda Furmaga-Jabłońska; Ryszard Maciejewski; Marzena Ułamek-Kozioł; Mirosław Jabłoński
Journal:  Mol Neurobiol       Date:  2012-10-19       Impact factor: 5.590

9.  Increased γ-secretase activity in idiopathic normal pressure hydrocephalus patients with β-amyloid pathology.

Authors:  Tiina Laiterä; Timo Sarajärvi; Annakaisa Haapasalo; Lakshman Puli; Tarja Kauppinen; Petra Mäkinen; Tuomas Rauramaa; Heikki Tanila; Juha E Jääskeläinen; Irina Alafuzoff; Hilkka Soininen; Ville Leinonen; Mikko Hiltunen
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

Review 10.  Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

Authors:  Ryszard Pluta; Mirosław Jabłoński; Marzena Ułamek-Kozioł; Janusz Kocki; Judyta Brzozowska; Sławomir Januszewski; Wanda Furmaga-Jabłońska; Anna Bogucka-Kocka; Ryszard Maciejewski; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2013-03-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.